Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation
- PMID: 3260905
- DOI: 10.1016/0165-5728(88)90033-1
Central catecholamine depletion impairs in vivo immunity but not in vitro lymphocyte activation
Abstract
We have previously shown that depletion of central nervous system (CNS) catecholamines by injecting the neurotoxin 6-hydroxydopamine (6-OHDA) into the cisterna magna of C57B1/6 mice markedly impairs the humoral immune response to sheep red blood cells. This work extends these observations by showing that 6-OHDA treatment also inhibits the humoral antibody response to the T-cell-dependent antigen trinitrophenyl-keyhole limpet hemocyanin, but does not affect the response to the T-independent antigen trinitrophenyl-lipopolysaccharide. This treatment also impairs humoral responsiveness at peripheral lymphoid sites in addition to inhibiting natural killer cell activity. However, 6-OHDA treatment in vivo does not affect in vitro mixed lymphocyte responsiveness, mitogen-induced lymphocyte activation or antigen presentation by macrophages.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
